Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-03-23Artery Elasticity After Switch From Epzicom to Truvada
-
CLINICAL_TRIALS study record update · 2012-03-22Examining the Ability of HSV2 Therapy to Reduce HIV Target Cell Numbers in the Cervix.
-
CLINICAL_TRIALS study record update · 2012-03-22A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2012-03-14Pilot Study to Evaluate the Immunogenicity and Safety of the HPV Quadrivalent Vaccine (Gardasil) in HIV-infected Men
-
CLINICAL_TRIALS study record update · 2012-03-13A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-03-09Randomized Clinical Trial of a Brazilian HIV Prevention Intervention for the Severely Mentally Ill
-
CLINICAL_TRIALS study record update · 2012-03-08Community Partnerships to Prevent Urban Youth Health Risks (CHAMPions)
-
CLINICAL_TRIALS study record update · 2012-03-05Zinc Therapy in Zinc Deficient HIV Positive Drug Users
-
CLINICAL_TRIALS study record update · 2012-02-29A Phase I Evaluation of the Safety and Biologic Activity of TXA127 in HIV-Infected Subjects With CD4+ T-Lymphocyte Counts Less Than 250 Per mm3 Who Have Responded to HAART
-
CLINICAL_TRIALS study record update · 2012-02-29The Effect of Vitamin D Supplementation on Endothelial Function, Inflammation and Insulin Resistance in HIV
-
CLINICAL_TRIALS study record update · 2012-02-24An Open Label, Phase IIIb, Randomised Parallel Group Study to Assess the Efficacy and Safety of Switching HIV-1 Infected Patients Successfully Treated With a Nevirapine IR Based Regiment to Nevirapine XR 400 mg QD or Remaining on Nevirapine IR 200 mg BID Based Program
-
CLINICAL_TRIALS study record update · 2012-02-24A Pilot Trial of Maraviroc for Treatment of Subjects on Antiretroviral Therapy With Suboptimal CD4 T-cell Count Recovery Despite Sustained Virologic Suppression
-
CLINICAL_TRIALS study record update · 2012-02-22Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and C Hepatitis Who Failed to Active Treatment for HCV. ANRSHC12 Fibrostop
-
CLINICAL_TRIALS study record update · 2012-02-17Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2012-02-16Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment Containing Enfuvirtide (Fuzeon) Associated With Two Active Molecules
-
CLINICAL_TRIALS study record update · 2012-02-15Safety and Efficacy of the Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations in Pregnant and Breastfeeding Women to Prevent mother-to Child Transmission of HIV-1 o, Resource-limited Settings: A Multicentre Randomized Phase 3 Clinical Trial
-
CLINICAL_TRIALS study record update · 2012-02-14Feasibility and Pilot Efficacy of Flash-heated Breast Milk for Reduction of Maternal-to-Child Transmission of HIV in Tanzania
-
CLINICAL_TRIALS study record update · 2012-02-09Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 ZW (Powder in Bottle Formulation) at 12.5 mg q24h, 12.5 mg q12h, 12.5 mg q8h, 25 mg q12h, 25 mg q8h, 50 mg q12h, 37.5 mg q8h and 50 mg q8h Dose Levels for 10 Days in Healthy Male Volunteers (Randomized, Double-blind Placebo-controlled Within Dose Groups)
-
CLINICAL_TRIALS study record update · 2012-02-09A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 Perinatally Infected Children and Youth
-
CLINICAL_TRIALS study record update · 2012-02-07A Randomized Clinical Trial of Immediate Versus Standard Antiretroviral Therapy for HIV-infected Adults Presenting With Cryptococcal Meningitis
-
CLINICAL_TRIALS study record update · 2012-02-03An Open Randomized Phase I Study Evaluating Safety and Immunogenicity of a Candidate HIV-1 Vaccine, MVA.HIVA, Administered to Healthy Infants Born to HIV-1/2-uninfected Mothers
-
CLINICAL_TRIALS study record update · 2012-01-30Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon
-
CLINICAL_TRIALS study record update · 2012-01-30A Double Blind Phase II Study of Multiple Doses of Palifermin (rHuKGF) for the Treatment of Inadequate CD4+ Lymphocyte Recovery in Subjects on Potent Antiretroviral Therapy With Plasma HIV-1 RNA Levels of 200 Copies Per Milliliter or Less
-
CLINICAL_TRIALS study record update · 2012-01-23A Phase 2b/3, Randomized, Double Blind, Dose Confirming Study of the Safety, Efficacy and Tolerability of Apricitabine Versus Lamivudine in Treatment-experienced HIV-1 Infected Patients With the M184V/I Mutation in Reverse Transcriptase
-
CLINICAL_TRIALS study record update · 2012-01-23Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison and Set up the Notional Halfway Home in Union Area of Medical Facility